Generative Bionics has secured €70 million in funding to advance the development of intelligent humanoid robots from Italy, focusing on industrial and healthcare applications.

Target Information

Generative Bionics is an innovative startup that emerged from the Italian Institute of Technology (IIT). The company specializes in the development of humanoid robots that combine advanced design with artificial intelligence to operate efficiently and safely in industrial contexts. Recently, Generative Bionics successfully closed a €70 million funding round, making it one of the most significant investments in deep tech related to humanoid robotics in Europe. The leadership of the company, spearheaded by CEO and co-founder Daniele Pucci, aims to bring to market a new generation of intelligent humanoid robots, particularly designed for applications in sectors such as healthcare and retail.

The robots are intended for repetitive tasks, environments with high risks, or operations that demand significant human effort. The funds raised will enhance product development, the training of Physical AI systems—which merges robotics with artificial intelligence—industrial validation, and the establishment of the first production facility. Additionally, the company is in the final stages of securing initial contracts with industrial manufacturing firms, with announcements expected in early 2026, marking a pivotal moment for the introduction of humanoids into real-world production settings.

Industry Overview

The humanoid robotics industry is rapidly evolving, driven by technological advancements and increasing demand across various sectors. According to international market analyses, the humanoid robotics market is projected to exceed €200